1-10 of 10
Yoshiko Okikawa
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical and genetic features of therapy-related myeloid neoplasms after chemotherapy for acute promyelocytic leukemia

Brief Report
Jun Imagawa, Yuka Harada, Takeshi Shimomura, Hideo Tanaka, Yoshiko Okikawa, Hideo Hyodo, Akiro Kimura, Hironori Harada
Journal: Blood
Blood (2010) 116 (26): 6018–6022.
https://doi.org/10.1182/blood-2010-06-289389
Published: 2010
Journal Articles

Levels of sIL-2R in Sera Depend On Number of CD25-Positive Lymphoma Cells and MMP-9-Positive Macrophages in DLBCL.

Noriaki Yoshida, MD, Akira Sakai, MD, PhD, Yoshiko Okikawa, MD, Yuta Katayama, MD, PhD, Hideki Asaoku, MD, Hirotaka Matsui, MD, PhD, Koji Arihiro, MD, PhD, Megumu Fujihara, MD, PhD, Takashi Nishisaka, MD, PhD, Naomi Sasaki, MD, PhD, Yoshito Sadahira, MD, PhD, Akiro Kimura, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2927.
https://doi.org/10.1182/blood.V114.22.2927.2927
Published: 2009
Journal Articles

Significance of Serum Soluble IL-2R in DLBCL and FL Is Different from That in ATL

Noriaki Yoshida, MD, Akira Sakai, MD, PhD, Yoshiko Okikawa, MD, Hideaki Nitta, MD, Takashi Nishisaka, MD, PhD, Akiro Kimura, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2817.
https://doi.org/10.1182/blood.V112.11.2817.2817
Published: 2008
Journal Articles

Cyclin D1 Overexpression Increases Chemosensitivity Via Prolonged S-Phase and TRAIL Signal in Myeloma Cell.

Yoshiaki Kuroda, MD, Akira Sakai, M.D., Naohiro Tsuyama, Ph.D., Yuta Katayama, M.D., Shoso Munemasa, M.D., Yoshiko Okikawa, M.D., Hideki Asaoku, M.D., Nanae Nakaju, Mami Mizuno, Takashi Nishizaka, M.D., Katsunari Ogawa, Hideo Tanaka, M.D., Akiro Kimura, M.D.
Journal: Blood
Blood (2007) 110 (11): 3530.
https://doi.org/10.1182/blood.V110.11.3530.3530
Published: 2007
Journal Articles

Immunomodulatory Thalidomide Analogs Do Not Affect Osteoprogenitor Differentiation and Low Concentration of Bortezomib Promotes It, While Both Agents Suppress Osteoclast Differentiation.

Shoso Munemasa, MD, Akira Sakai, M.D., Yoshiaki Kuroda, M.D., Yoshiko Okikawa, M.D., Yuta Katayama, M.D., Hideki Asaoku, M.D., Tadahiko Kubo, M.D., Shoji Shimose, M.D., Akiro Kimura, M.D.
Journal: Blood
Blood (2007) 110 (11): 4780.
https://doi.org/10.1182/blood.V110.11.4780.4780
Published: 2007
Journal Articles

Cyclin D1 Overexpression Increases Chemosensitivity Via the Induction of Bim in Myeloma Cells.

Yoshiaki Kuroda, MD, Akira Sakai, M.D., Naohiro Tsuyama, Ph.D., Shoso Munemasa, M.D., Nanae Nakaju, Mami Mizuno, Yoshiko Okikawa, M.D., Yuta Katayama, M.D., Akiro Kimura, M.D.
Journal: Blood
Blood (2006) 108 (11): 3418.
https://doi.org/10.1182/blood.V108.11.3418.3418
Published: 2006
Journal Articles

Connective Tissue Growth Factor (CTGF) Is an Indicator of Bone Involvement in Multiple Myeloma.

Shoso Munemasa, MD, Akira Sakai, M.D., Yoshiaki Kuroda, M.D., Yoshiko Okikawa, M.D., Yuta Katayama, M.D., Hideki Asaoku, M.D., Tadahiko Kubo, M.D., Noelynn Oliver, Ph.D., Akiro Kimura, M.D.
Journal: Blood
Blood (2006) 108 (11): 5025.
https://doi.org/10.1182/blood.V108.11.5025.5025
Published: 2006
Journal Articles

Induction of Cyclin D1 Gene in Myeloma Cells Down-Regulates the Expression of Cyclin D2.

Yoshiaki Kuroda, MD, Akira Sakai, MD, Naohiro Tsuyama, PhD, Mami Mizuno, Nanae Nakaju, Shoso Munemasa, MD, Yoshiko Okikawa, MD, Yuta Katayama, MD, Akiro Kimura, MD
Journal: Blood
Blood (2005) 106 (11): 3411.
https://doi.org/10.1182/blood.V106.11.3411.3411
Published: 2005
Journal Articles

What Is Important Factor of Bone Disease in Multiple Myeloma?.

Shoso Munemasa, M.D., Akira Sakai, M.D., Yoshiko Okikawa, M.D., Yoshiaki Kuroda, M.D., Yuta Katayama, M.D., Hideki Asaoku, M.D., Akiro Kimura, M.D.
Journal: Blood
Blood (2004) 104 (11): 4855.
https://doi.org/10.1182/blood.V104.11.4855.4855
Published: 2004
Journal Articles

The Reason Why High-Dose Melphalan Followed by Autologous Stem-Cell Transplantation Produces Good Response in Multiple Myeloma.

Yoshiaki Kuroda, M.D., Akira Sakai, M.D., Yoshiko Okikawa, M.D., Shoso Munemasa, M.D., Yuta Katayama, M.D., Yasuo Takimoto, M.D., Hajime Okita, M.D., Akiro Kimura, M.D.
Journal: Blood
Blood (2004) 104 (11): 5201.
https://doi.org/10.1182/blood.V104.11.5201.5201
Published: 2004